Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Trigeminal neuralgia, Vertigo
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 13Aug2021 16:30 (Lot number: FC3180) at the age of 58 years as dose 2, single for Covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing); "PCOS" (unspecified if ongoing); "OA" (unspecified if ongoing); "Intermittant Vertigo" (unspecified if ongoing); "Trigeminal Neuralgia" (unspecified if ongoing). Concomitant medication(s) included: TELMISARTAN; HYDRALAZINE. Past drug history included: Tylox. Vaccination history included: Bnt162b2 (Dose 1, Single, Lot number: FW0181, Administration date and time 23Jul2021 at 12:45 PM, Vaccine location: Right arm), administration date: 23Jul2021, when the patient was 58 years old, for Covid-19 immunization, reaction(s): "Within 15 min HA/HA 5 or 5 days", "Dizziness lasting 3 days in bed", "Later that day Chills/Fever", "Later that day Chills/Fever", "Full Body Aches", "Not feeling well". The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "not recovered", described as "Same except HA (migraine like) ongoing after 2 weeks and counting"; MIGRAINE (non-serious) with onset 2021, outcome "not recovered", described as "Same except HA (migraine like) ongoing after 2 weeks and counting"; VERTIGO (non-serious) with onset 2021, outcome "not recovered", described as "intermittent vertigo"; OSTEOARTHRITIS (non-serious) with onset 2021, outcome "not recovered", described as "flareups of hand/wrists OA"; TRIGEMINAL NEURALGIA (non-serious) with onset 2021, outcome "not recovered", described as "vertigo and trigeminal neuralgia requiring pain meds"; SWELLING (non-serious), PHARYNGEAL SWELLING (non-serious) all with onset 2021, outcome "not recovered" and all described as "Mild swelling of nasal/throat requiring Benadryl 24hrs. Still taking pain meds for HA". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, migraine, vertigo, osteoarthritis, trigeminal neuralgia, swelling, pharyngeal swelling. Additional information: After 1st dose, the patient reported adverse event included within 15 min headache, dizziness, later that day chills/fever, full body aches, not feeling well, dizziness lasting 3 days in bed and headache 5 or 5 days. After 2nd dose, the patient also reported adverse event included same except headache (migraine like) ongoing after 2 weeks and counting, intermittent vertigo, flareups of hand/wrists osteoarthritis, vertigo and trigeminal neuralgia requiring pain meds. Mild swelling of nasal/throat requiring Benadryl 24 hrs. Still taking pain medications for headache. The patient had allergies to some other pain medications which she did not remember names. Facility type vaccine: Pharmacy or Drug Store. The patient did not receive other vaccine in four weeks, but receive other medications Telmisartan 80mg QD, and Hydralazine50 mg TID in two weeks. The patient did not have Covid-19 prior vaccination. The patient tested for Covid-19 post vaccination. On 16Aug2021 and 23Aug2021, Covid-19 test type post vaccination included Nasal Swab which showed Covid-19 test result negative. No follow-up attempts are possible. No further information is expected.